Purification of mupirocin

Details for Australian Patent Application No. 2006215708 (hide)

Owner Xellia Pharmaceuticals ApS

Inventors Aassveen, Lene; Mathiesen, Anita; Reijns, Tiem Geert Pieter; Bisschops, Marc Antonius Theodorus

Agent Fisher Adams Kelly

Pub. Number AU-B-2006215708

PCT Pub. Number WO2006/087237

Priority PA 2005 00261 21.02.05 DK

Filing date 21 February 2006

Wipo publication date 24 August 2006

Acceptance publication date 27 January 2011

International Classifications

C07D 407/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/087237 Priority application(s): WO2006/087237

13 November 2008 Alteration of Name

  The name of the applicant has been altered to Axellia Pharmaceuticals ApS

21 October 2010 Alteration of Name

  The name of the applicant has been altered to Xellia Pharmaceuticals ApS

27 January 2011 Application Accepted

  Published as AU-B-2006215708

26 May 2011 Standard Patent Sealed

5 July 2012 Assignment Registered

  Xellia Pharmaceuticals ApS The patent has been assigned to Syngen Biotech Co., Ltd

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006215709-Method for the production of macrolides

2006215703-L-aspartic acid for the treatment of problems in connection with the fat or glucose metabolism